Add this topic to your myFT Digest for news straight to your inbox
Share price in addiction treatment specialist loses almost a quarter of value
Drugmaker to divest product in order to focus on core offerings
Drugmaker’s stock price drops to lowest point since May 2016
Shares have been repeatedly falling, but a new drug should break the cycle
Addiction treatment specialist scraps revenue guidance for financial year
UK drugmaker slides on news rival opioid addiction treatment does not infringe patents
FTSE 100 dips 15.35 points lower at 7,715.44
Companies analysis from our sister publication
Drugmaker cleared by US regulatory panel to take on opioid emergency
Analysts see buying opportunity as UK drugmaker readies new opioid addiction injection
UK drugs group faces a generic threat but the market’s withdrawal is too severe
International Edition